You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CLINICAL TRIALS PROFILE FOR ALFENTA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ALFENTA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00672438 ↗ Heritability of Opioid Effects: A Twin Study Completed SRI International N/A 2008-05-01 Proposed twin study will test to what degree inter-individual differences in pain sensitivity and amount of pain relief in response to opioid therapy are inherited or alternatively, are due to environmental factors. This knowledge is important to guide future studies trying to explain such inter-individual differences. For example, finding that differences are largely due to environmental factors would discourage genomic studies and emphasize epidemiological studies.
NCT00672438 ↗ Heritability of Opioid Effects: A Twin Study Completed Martin Angst N/A 2008-05-01 Proposed twin study will test to what degree inter-individual differences in pain sensitivity and amount of pain relief in response to opioid therapy are inherited or alternatively, are due to environmental factors. This knowledge is important to guide future studies trying to explain such inter-individual differences. For example, finding that differences are largely due to environmental factors would discourage genomic studies and emphasize epidemiological studies.
NCT01350037 ↗ Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP) Completed Helsinki University Central Hospital Phase 4 2009-06-01 Self-administration of propofol and opioid mixture by the patient him- or herself (patient-controlled sedation, PCS) could be successful alternative to the anesthesiologists-managed deep sedation during endoscopic retrograde cholangiopancreatography (ERCP). However, it is not known which opioid would be the most suitable for PCS. The aim of this double-blind study was to compare remifentanil and alfentanil in PCS during ERCP.
NCT02000206 ↗ Comparison of Propofol/Alfentanil With Propofol/Ketamine Unknown status Rabin Medical Center N/A 2014-02-01 A prospective, randomized, patient-blinded comparison of the safety and efficacy of conscious sedation by propofol/alfentanil with propofol/ketamine in patients undergoing flexible fiberoptic bronchoscopy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ALFENTA

Condition Name

Condition Name for ALFENTA
Intervention Trials
Biliary Tract Diseases 1
Lung Disease 1
Pain 1
Pancreatic Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ALFENTA
Intervention Trials
Biliary Tract Diseases 1
Lung Diseases 1
Pancreatic Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ALFENTA

Trials by Country

Trials by Country for ALFENTA
Location Trials
United States 1
Israel 1
Finland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ALFENTA
Location Trials
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ALFENTA

Clinical Trial Phase

Clinical Trial Phase for ALFENTA
Clinical Trial Phase Trials
Phase 4 1
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ALFENTA
Clinical Trial Phase Trials
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ALFENTA

Sponsor Name

Sponsor Name for ALFENTA
Sponsor Trials
SRI International 1
Martin Angst 1
Helsinki University Central Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ALFENTA
Sponsor Trials
Other 3
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.